These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 36692197)

  • 1. Molecular Modeling Study of a Receptor-Orthosteric Ligand-Allosteric Modulator Signaling Complex.
    Jiang C; He X; Wang Y; Chen CJ; Othman Y; Hao Y; Yuan J; Xie XQ; Feng Z
    ACS Chem Neurosci; 2023 Feb; 14(3):418-434. PubMed ID: 36692197
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How Do Modulators Affect the Orthosteric and Allosteric Binding Pockets?
    Chen CJ; Jiang C; Yuan J; Chen M; Cuyler J; Xie XQ; Feng Z
    ACS Chem Neurosci; 2022 Apr; 13(7):959-977. PubMed ID: 35298129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Negative allosteric modulators of cannabinoid receptor 2: protein modeling, binding site identification and molecular dynamics simulations in the presence of an orthosteric agonist.
    Pandey P; Roy KK; Doerksen RJ
    J Biomol Struct Dyn; 2020 Jan; 38(1):32-47. PubMed ID: 30652534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Allosteric Binding Site and Activation Mechanism of Class C G-Protein Coupled Receptors: Metabotropic Glutamate Receptor Family.
    Feng Z; Ma S; Hu G; Xie XQ
    AAPS J; 2015 May; 17(3):737-53. PubMed ID: 25762450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric activation of metabotropic glutamate receptor 5.
    Jójárt B; Orgován Z; Márki Á; Pándy-Szekeres G; Ferenczy GG; Keserű GM
    J Biomol Struct Dyn; 2020 Jun; 38(9):2624-2632. PubMed ID: 31258022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homology modeling, docking, and molecular dynamics simulation of the receptor GALR2 and its interactions with galanin and a positive allosteric modulator.
    Hui WQ; Cheng Q; Liu TY; Ouyang Q
    J Mol Model; 2016 Apr; 22(4):90. PubMed ID: 27021209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Revealing the Positive Binding Cooperativity Mechanism between the Orthosteric and the Allosteric Antagonists of CCR2 by Metadynamics and Gaussian Accelerated Molecular Dynamics Simulations.
    An X; Bai Q; Bing Z; Liu H; Zhang Q; Liu H; Yao X
    ACS Chem Neurosci; 2020 Feb; 11(4):628-637. PubMed ID: 31968162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Silico Prediction and Validation of CB2 Allosteric Binding Sites to Aid the Design of Allosteric Modulators.
    Yuan J; Jiang C; Wang J; Chen CJ; Hao Y; Zhao G; Feng Z; Xie XQ
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the Second Extracellular Loop of the Adenosine A1 Receptor on Allosteric Modulator Binding, Signaling, and Cooperativity.
    Nguyen AT; Vecchio EA; Thomas T; Nguyen TD; Aurelio L; Scammells PJ; White PJ; Sexton PM; Gregory KJ; May LT; Christopoulos A
    Mol Pharmacol; 2016 Dec; 90(6):715-725. PubMed ID: 27683013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Negative allosteric modulators of cannabinoid receptor 1: Ternary complexes including CB1, orthosteric CP55940 and allosteric ORG27569.
    Aderibigbe AO; Pandey P; Doerksen RJ
    J Biomol Struct Dyn; 2022 Aug; 40(13):5729-5747. PubMed ID: 33480332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between allosteric and orthosteric binding sites of γ-amino butyric acid type A receptors (GABA
    Payghan PV; Nath Roy S; Bhattacharyya D; Ghoshal N
    J Biomol Struct Dyn; 2019 Aug; 37(12):3065-3080. PubMed ID: 30608219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cooperativity between the orthosteric and allosteric ligand binding sites of RORγt.
    de Vries RMJM; Meijer FA; Doveston RG; Leijten-van de Gevel IA; Brunsveld L
    Proc Natl Acad Sci U S A; 2021 Feb; 118(6):. PubMed ID: 33536342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational fingerprinting of allosteric modulators in metabotropic glutamate receptor 2.
    Liauw BW; Foroutan A; Schamber MR; Lu W; Samareh Afsari H; Vafabakhsh R
    Elife; 2022 Jul; 11():. PubMed ID: 35775730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probing the metabotropic glutamate receptor 5 (mGlu₅) positive allosteric modulator (PAM) binding pocket: discovery of point mutations that engender a "molecular switch" in PAM pharmacology.
    Gregory KJ; Nguyen ED; Reiff SD; Squire EF; Stauffer SR; Lindsley CW; Meiler J; Conn PJ
    Mol Pharmacol; 2013 May; 83(5):991-1006. PubMed ID: 23444015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing the druggability at orthosteric and allosteric sites of PD-1 for small molecule discovery by an integrated in silico pipeline.
    Mittal L; Tonk RK; Awasthi A; Asthana S
    Comput Biol Chem; 2023 Dec; 107():107965. PubMed ID: 37826990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Un-gating and allosteric modulation of a pentameric ligand-gated ion channel captured by molecular dynamics.
    Martin NE; Malik S; Calimet N; Changeux JP; Cecchini M
    PLoS Comput Biol; 2017 Oct; 13(10):e1005784. PubMed ID: 29069080
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation mechanism of the μ-opioid receptor by an allosteric modulator.
    Kaneko S; Imai S; Asao N; Kofuku Y; Ueda T; Shimada I
    Proc Natl Acad Sci U S A; 2022 Apr; 119(16):e2121918119. PubMed ID: 35412886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of equilibrium binding of an orthosteric tracer and two allosteric modulators.
    Jakubík J; Randáková A; El-Fakahany EE; Doležal V
    PLoS One; 2019; 14(3):e0214255. PubMed ID: 30917186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A
    Lu Y; Liu H; Yang D; Zhong L; Xin Y; Zhao S; Wang MW; Zhou Q; Shui W
    ACS Chem Biol; 2021 Jun; 16(6):991-1002. PubMed ID: 34048655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probe dependence and biased potentiation of metabotropic glutamate receptor 5 is mediated by differential ligand interactions in the common allosteric binding site.
    Hellyer SD; Sengmany K; Keller AN; Christopoulos A; Leach K; Gregory KJ
    Biochem Pharmacol; 2020 Jul; 177():114013. PubMed ID: 32389635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.